Expression and distribution of MUC18 in human uveal melanoma

Virchows Archiv

Volumn 451, Issue 5, 2007, Pages 967-976

  Lai, Kenneth ^a   Sharma, Vidushi ^a   Jager, Martine J ^b   Conway, R Max ^a   Madigan, Michele C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Immunohistochemistry; Oncology; Uveal melanoma; Vascular endothelium

Indexed keywords

MESSENGER RNA; MUCIN; MUCIN 18; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VASCULARIZATION; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD146; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; RETINA; UVEAL NEOPLASMS;

EID: 35848963614     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0498-0     Document Type: Article

References (59)

1. Aldovini D, Demichelis F, Doglioni C, Di Vizio D, Galligioni E, Brugnara S, Zeni B, Griso C, Pegoraro C, Zannoni M, Gariboldi M, Balladore E, Mezzanzanica D, Canevari S, Barbareschi M (2006) M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. Int J Cancer 119:1920-1926
2. Anfosso F, Bardin N, Frances V, Vivier E, Camoin-Jau L, Sampol J, Dignat-George F (1998) Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125(FAK). J Biol Chem 273:26852-26856
3. Anfosso F, Bardin N, Vivier E, Sabatier F, Sampol J, Dignat-George F (2001) Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 276:1564-1569
4. Bar-Eli M (1999) Role of AP-2 in tumor growth and metastasis of human melanoma. Cancer Metastasis Rev 18:377-385
5. Bardin N, Anfosso F, Masse JM, Cramer E, Sabatier F, Le Bivic A, Sampol J, Dignat-George F (2001) Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 98:3677-3684
6. Bardin N, Frances V, Lesaule G, Horschowski N, George F, Sampol J (1996) Identification of the S-Endo 1 endothelial-associated antigen. Biochem Biophys Res Commun 218:210-216
7. Bardin N, George F, Mutin M, Brisson C, Horschowski N, Frances V, Lesaule G, Sampol J (1996) S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 48:531-539
8. Bosher JM, Williams T, Hurst HC (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 92:744-747
9. Denton KJ, Stretch JR, Gatter KC, Harris AL (1992) A study of adhesion molecules as markers of progression in malignant melanoma. J Pathol 167:187-191
10. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP Jr (2005) CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 106:2923-2924
11. Folberg R, Hendrix MJ, Maniotis AJ (2000) Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 156:361-381
12. Folberg R, Maniotis AJ (2004) Vasculogenic mimicry. APMIS 112:508-525
13. Folberg R, Pe'er J, Gruman LM, Woolson RF, Jeng G, Montague PR, Moninger TO, Yi H, Moore KC (1992) The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. Hum Pathol 23:1298-1305
14. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, Hwang T, Woolson RF, Pe'er J, Gruman LM (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100:1389-1398
15. Gambrelle J, Grange JD, Devouassoux Shisheboran M, Rivoire M, Baggetto LG, Jean-Louis B, Fleury J, Kodjikian L (2006) Survival after primary enucleation for choroidal melanoma: changes induced by the introduction of conservative therapies. Graefes Arch Clin Exp Ophthalmol 245:657-663
16. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD (1991) Survival of patients with metastases from uveal melanoma. Ophthalmology 98:383-389 (discussion 390)
17. Haass NK, Smalley KS, Li L, Herlyn M (2005) Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 18:150-159
18. Heimberger AB, McGary EC, Suki D, Ruiz M, Wang H, Fuller GN, Bar-Eli M (2005) Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas. Clin Cancer Res 11:267-272
19. Hendrix MJ, Seftor EA, Kirschmann DA, Quaranta V, Seftor RE (2003) Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann N Y Acad Sci 995:151-161
20. Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M (1998) Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. J Biol Chem 273:16501-16508
21. Johnson JP (1994) Identification of molecules associated with the development of metastasis in human malignant melanoma. Invasion Metastasis 14:123-130
22. Karlen S, Braathen LR (1999) Regulation of the melanoma cell adhesion molecule gene in melanoma: modulation of mRNA synthesis by cyclic adenosine monophosphate, phorbol ester, and stem cell fFactor/c-kKit signaling. J Invest Dermatol 113:711-719
23. Karlen S, Braathen LR (2000) Role of the initiator element in the regulation of the melanoma cell adhesion molecule gene. J Invest Dermatol 115:668-673
24. Kodjikian L, Grange JD, Baldo S, Baillif S, Garweg JG, Rivoire M (2005) Prognostic factors of liver metastases from uveal melanoma. Graefes Arch Clin Exp Ophthalmol 243:985-993
25. Kraus A, Masat L, Johnson JP (1997) Analysis of the expression of intercellular adhesion molecule-1 and MUC18 on benign and malignant melanocytic lesions using monoclonal antibodies directed against distinct epitopes and recognizing denatured, non-glycosylated antigen. Melanoma Res 7(Suppl 2):S75-S81
26. Lai K, Di Girolamo N, Conway RM, Jager MJ, Madigan MC (2007) The effect of ultraviolet radiation on choroidal melanocytes and melanoma cell lines: cell survival and matrix metalloproteinase production. Graefes Arch Clin Exp Ophthalmol 245:715-724
27. Lehmann JM, Holzmann B, Breitbart EW, Schmiegelow P, Riethmuller G, Johnson JP (1987) Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000. Cancer Res 47:841-845
28. Lehmann JM, Riethmuller G, Johnson JP (1989) MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86:9891-9895
29. Leslie MC, Bar-Eli M (2005) Regulation of gene expression in melanoma: new approaches for treatment. J Cell Biochem 94:25-38
30. Leslie MC, Zhao YJ, Lachman LB, Hwu P, Bar-Eli M (2006) Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Ther 14:316-323
31. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739-752
32. McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M (2003) A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. Clin Cancer Res 9:6560-6566
33. Meier F, Schittek B, Busch S, Garbe C, Smalley K, Satyamoorthy K, Li G, Herlyn M (2005) The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci 10:2986-3001
34. Melnikova VO, Bar-Eli M (2006) Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res 19:395-405
35. Mintz-Weber CS, Johnson JP (2000) Identification of the elements regulating the expression of the cell adhesion molecule MCAM/MUC18. Loss of AP-2 is not required for MCAM expression in melanoma cell lines. J Biol Chem 275:34672-34680
36. Onken MD, Lin AY, Worley LA, Folberg R, Harbour JW (2005) Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Am J Ophthalmol 140:748-749
37. Pacifico MD, Grover R, Richman PI, Daley FM, Buffa F, Wilson GD (2005) Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker. Plast Reconstr Surg 115:367-375
38. Pardo M, Garcia A, Thomas B, Pineiro A, Akoulitchev A, Dwek RA, Zitzmann N (2005) Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS. Proteomics 5:4980-4993
39. Pardo M, Garcia A, Thomas B, Pineiro A, Akoulitchev A, Dwek RA, Zitzmann N (2006) The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer 119:1014-1022
40. Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Fae I, Waclavicek M, Stockl J, Scheinecker C, Vidicki T, Aschauer H, Johnson JP, Knapp W (1997) MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 158:2107-2115
41. Rivoire M, Kodjikian L, Baldo S, Kaemmerlen P, Negrier S, Grange JD (2005) Treatment of liver metastases from uveal melanoma. Ann Surg Oncol 12:422-428
42. Ruiz M, Troncoso P, Bruns C, Bar-Eli M (2001) Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer. Clin Cancer Res 7:4086-4095
43. Seddon J, Egan K, Gragoudas E (1994) Epidemiology of Uveal Melanoma. Retina 1:717-723
44. Seftalioglu A, Karakoc L (2000) Expression of CD146 adhesion molecules (MUC18 or MCAM) in the thymic microenvironment. Acta Histochem 102:69-83
45. Seftor EA, Meltzer PS, Kirschmann DA, Margaryan NV, Seftor RE, Hendrix MJ (2006) The epigenetic reprogramming of poorly aggressive melanoma cells by a metastatic microenvironment. J Cell Mol Med 10:174-196
46. Seftor EA, Meltzer PS, Kirschmann DA, Pe'er J, Maniotis AJ, Trent JM, Folberg R, Hendrix MJ (2002) Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 19:233-246
47. Sers C, Riethmuller G, Johnson JP (1994) MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Cancer Res 54:5689-5694
48. Shih IM (1999) The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 189:4-11
49. Shih IM, Nesbit M, Herlyn M, Kurman RJ (1998) A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol 11:1098-1106
50. Shih IM, Speicher D, Hsu MY, Levine E, Herlyn M (1997) Melanoma cell-cell interactions are mediated through heterophilic Mel-CAM/ligand adhesion. Cancer Res 57:3835-3840
51. Shih IM, Wang TL, Westra WH (1996) Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms. Clin Cancer Res 2:569-575
52. Solovey AN, Gui L, Chang L, Enenstein J, Browne PV, Hebbel RP (2001) Identification and functional assessment of endothelial P1H12. J Lab Clin Med 138:322-331
53. Stang A, Schmidt-Pokrzywniak A, Lehnert M, Parkin DM, Ferlay J, Bornfeld N, Marr A, Jockel KH (2006) Population-based incidence estimates of uveal melanoma in Germany. Supplementing cancer registry data by case-control data. Eur J Cancer Prev 15:165-170
54. Tellez C, Bar-Eli M (2003) Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 22:3130-3137
55. Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK (2003) Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Can 105:117-122
56. van der Velden PA, Zuidervaart W, Hurks MH, Pavey S, Ksander BR, Krijgsman E, Frants RR, Tensen CP, Willemze R, Jager MJ, Gruis NA (2003) Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 106:472-479
57. Watson-Hurst K, Becker D (2006) The role of N-cadherin, MCAM and beta(3) integrin in melanoma progression, proliferation, migration and invasion. Cancer Biol Ther 5:1375-1382
58. Wu GJ, Varma VA, Wu MW, Wang SW, Qu P, Yang H, Petros JA, Lim SD, Amin MB (2001) Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Prostate 48:305-315
59. Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M (1997) Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Cancer Res 57:2295-2303